Physician profile
Aaron Lesher
NPI 1710077896
$8,044.89
in general payments reported to CMS, 2019-2025
11 companies · $369 in 2025
The $369 reported for 2025 was more than what 76% of Pediatric Surgery providers received nationally (typical 2025 total: $136).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2020: $17.11 · 2021: $594 · 2022: $234 · 2023: $416 · 2024: $6,029 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Travel and Lodging: $1,643 · Food and Beverage: $1,171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Travel and Lodging | $1,642.88 |
| Food and Beverage | $1,171.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,892.41 | 2024 | |
| Atricure, INC. | $768.61 | 2020-2025 | Atricure Cryoice Cryoablation System (Cryo2) |
| Integra Lifesciences Corporation | $448.74 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Ethicon US, LLC | $258.59 | 2019-2025 | Echelon; Endopath |
| Avita Medical Americas, LLC | $221.00 | 2024-2025 | Permeaderm, Cohealyx, Recell |
| Acera Surgical, INC. | $164.52 | 2019-2021 | |
| Kerecis Limited | $144.07 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Conmed Corporation | $43.05 | 2021 | |
| Depuy Synthes Sales INC. | $41.02 | 2023 | Zipfix, Matrixrib, Xcm Biologic Tissue Matrix |
| Medtronic, INC. | $39.71 | 2024 | Signia |
| Bolder Surgical LLC | $23.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Lesher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.